Distance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysis

Thomas, Audrey Alforque; O'Ceilleachair, A; Pearce, Alison; Sharp, Linda; Molcho, Michal

doi:10.1007/s00520-014-2407-9

Cited by 26 publications

(24 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study methods have been described in detail elsewhere [ 24 ]. Briefly, survivors of primary invasive colorectal cancer diagnosed between October 2007 and September 2009 were identified from the National Cancer Registry Ireland (NCRI) in March 2010, and screened for study eligibility by their treating clinicians.…”

Section: Methodsmentioning

confidence: 99%

Colorectal cancer survivors: an investigation of symptom burden and influencing factors

et al. 2018

Self Cite

View full text Add to dashboard Cite

BackgroundColorectal cancer is a significant issue internationally, with over 1.3 million people diagnosed annually. Survival rates are increasing as treatments improve, although physical symptoms can persist despite eradication of the tumour. In order to optimize survivorship care, further research is warranted in relation to symptom burden. Therefore, the objectives of this study are to (i) investigate frequency of physical symptoms in colorectal cancer survivors (ii) identify which symptoms occur together (iii) examine the associations between demographic and clinical variables, and symptoms.MethodsParticipants nine months to three years post diagnosis were identified from the population-based National Cancer Registry Ireland. Respondents completed the EORTC QLQ-C30 and EORTC QLQ-CR29. Reported physical symptom frequencies were transformed into continuous scale variables, which were then analysed using one way analysis of variance, general linear modelling and Spearman rank correlations.ResultsThere were 496 participants. Fatigue, insomnia and flatulence were the most frequent symptoms, with ≥20% of respondents reporting these to be often present in the previous week. Eight other symptoms were experienced often by 10–20% of respondents. At least one of these eleven most common symptoms was experienced frequently by almost every respondent (99%). 66% of respondents experienced at least two of these symptoms together, and 16% experienced five or more together. Current stoma was the single most common variable associated with increased symptom scores, although statistically significant relationships (p ≤ 0.05) between symptom frequency scores and clinical/demographic variables were generally weak (R-sq value ≤0.08).ConclusionFindings may inform targeted interventions during the nine month to three year post diagnosis timeframe, which would enable supported self-management of symptoms.Electronic supplementary materialThe online version of this article (10.1186/s12885-018-4923-3) contains supplementary material, which is available to authorized users.

show abstract

Section: Methodsmentioning

confidence: 99%

Colorectal cancer survivors: an investigation of symptom burden and influencing factors

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…Regardingthe association between travel burden and QoL,the results of the study by Thomas et al [6] suggest that remote colorectal cancer survivors, women in particular, have more trouble with daily activities, which was evidenced by their lower physical functioning scores. The lower role functioning scores for remote female colorectal cancer survivors suggest that they might feel unable to work or that they are limited in their ability to work.…”

Section: Regional Australiamentioning

confidence: 99%

Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature

et al. 2015

View full text Add to dashboard Cite

The burden of travel from a patient's residence to health care providers is an important issue that can influence access to diagnosis and treatment of cancer. Although several studies have shown that the travel burden can result in delays in diagnosis and treatment of many common cancers, its role appears underestimated in the treatment of patients in clinical practice. Therefore, we performed a review of the published data on the role of travel burden influencing four items: delay of diagnosis, adequate treatment of cancer, outcome, and quality of life of cancer patients. Forty‐seven studies published up to December 2014 were initially identified. Twenty studies were excluded because they did not regard specifically the four items of our review. Twenty‐seven studies formed the basis of our study and involved 716,153 patients. The associations between travel burden and (a) cancer stage at diagnosis (12 studies), (b) appropriate treatment (8 studies), (c) outcome (4 studies), and (d) quality of life (1 study) are reported. In addition, in two studies, the relation between travel burden and compliance with treatment was examined. The results of our review show that increasing travel requirements are associated with more advanced disease at diagnosis, inappropriate treatment, a worse prognosis, and a worse quality of life. These results suggest that clinical oncologists should remember the specific travel burden problem for cancer patients, who often need health care services every week or every month for many years. Implications for Practice: The influence of travel burden on cancer patients has been previously studied, but this is the first comprehensive review of the available literature. This review shows that travel burden negatively influences stage at diagnosis, appropriate treatment, outcome, and quality of life in cancer patients. The results demonstrate that clinical oncologists should keep in mind the specific travel burden problem for cancer patients who often need health care services every week or every month for many years.

show abstract

“…Factors that have facilitated this increased usage include the accumulating evidence that measures of HRQoL are valid and reliable, and outcome measures are responsive to important clinical changes. When patient describes or characterizes what they experienced as a result of medical care, they are useful and important supplements to traditional physiological or biological measures of health care [31][32][33][34][35][36] .…”

Section: Author's Disclosures Of Potential Conflicts Of Interestmentioning

confidence: 99%

Zdrave životne navike i kvaliteta života onkoloških bolesnika

Fičko

Smrekar

Hošnjak

et al. 2019

J. appl. health sci. (Online)

View full text Add to dashboard Cite

Background: Multiple health behavior change interventions, especially promoting the improvements in diet and exercise behaviors, have been used to ameliorate the adverse effects of cancer and its treatment. It is a well known fact that healthy lifestyle has a significant impact on cancer cases. The group of people which are at a high risk of cancer are smokers, people with low fruit and vegetable intake, people with a drinking problem and with low physical activity. In 43% of the cases the incidence of cancer can be prevented by conducting adequate measures. Aim: The aim of this study is an overview of health promotion behaviors such as non-smoking, non-alcohol abuse, physical activity, diet and body weight and their impact on quality of life among cancer patients and cancer survivors. Methods: Literature overview was made systematically. Studies that have been included in the final analysis, were analyzed through 4 steps. After reviewing the abstract, 6 full text articles were examined in more detail for eligibility and were included in the final data analysis. Results: All six articles have shown that patients with healthy lifestyle and those who are conducting health promotion behaviors have greater score on the quality of life questionnaire. Physical activity has an impact on symptoms of treatment and disease. Conclusion: This study supports the need for future research on public health view on conducting healthy lifestyle during therapy and in the remission of disease. Health promotion behaviors have great impact on quality of life among cancer patients and cancer survivors.

show abstract

Distance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysis

Cited by 26 publications

References 34 publications

Colorectal cancer survivors: an investigation of symptom burden and influencing factors

Colorectal cancer survivors: an investigation of symptom burden and influencing factors

Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature

Zdrave životne navike i kvaliteta života onkoloških bolesnika

Contact Info

Product

Resources

About